Loading…
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $515M | $-12M | $-50M | $-25M | -25.9% | -5.9% | -60.5% |
| 2024 | $547M | $-82M | $-126M | $-4M | -54.2% | -5.5% | -1780.3% |
| 2023 | $579M | $45M | $8M | $-71M | 2.0% | -5.0% | -72.6% |
| 2022 | $610M | $62M | $27M | $43M | 7.4% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 609.62 | 579.37 | 547.31 | 515.11 |
| Operating Revenue | - | 609.62 | 579.37 | 547.31 | 515.11 |
| Cost Of Revenue | - | 417.23 | 400.21 | 426.99 | 367.55 |
| Gross Profit | - | 192.39 | 179.16 | 120.32 | 147.56 |
| Operating Expense | - | 151.74 | 154.91 | 151.11 | 133.79 |
| Research And Development | - | 31.82 | 38.02 | 32.66 | 23.16 |
| Selling General And Administration | - | 119.92 | 116.89 | 105.11 | 98.51 |
| Total Expenses | - | 568.96 | 555.12 | 578.10 | 501.35 |
| Operating Income | - | 40.65 | 24.25 | -30.79 | 13.77 |
| Total Operating Income As Reported | - | 40.65 | 23.30 | -101.56 | -28.30 |
| EBITDA | - | 62.06 | 44.72 | -81.59 | -11.79 |
| Normalized EBITDA | - | 62.79 | 46.03 | -8.47 | 30.71 |
| EBIT | - | 39.92 | 22.94 | -103.91 | -30.53 |
| Interest Income | 0.06 | 0.17 | 0.37 | - | 0.11 |
| Interest Expense | - | 3.95 | 12.64 | 16.55 | 16.67 |
| Net Interest Income | - | -3.95 | -12.64 | -16.55 | -18.47 |
| Other Non Operating Income Expenses | 0.67 | - | - | - | - |
| Other Income Expense | - | -0.73 | -1.32 | -73.12 | -42.50 |
| Interest Income Non Operating | 0.06 | 0.17 | 0.37 | - | 0.11 |
| Interest Expense Non Operating | - | 3.95 | 12.64 | 16.55 | 16.67 |
| Net Non Operating Interest Income Expense | - | -3.95 | -12.64 | -16.55 | -18.47 |
| Pretax Income | - | 35.97 | 10.30 | -120.46 | -47.20 |
| Tax Provision | - | 8.56 | 2.78 | 5.88 | 2.68 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -0.17 | -0.36 | -15.35 | -8.93 |
| Net Income Continuous Operations | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income From Continuing And Discontinued Operation | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income From Continuing Operation Net Minority Interest | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income Common Stockholders | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income Including Noncontrolling Interests | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Normalized Income | - | 27.96 | 8.48 | -68.58 | -16.31 |
| Diluted NI Availto Com Stockholders | - | 27.40 | 7.52 | -126.34 | -49.88 |
| Basic Average Shares | - | 29.23 | 28.13 | 28.06 | 28.43 |
| Diluted Average Shares | - | 29.87 | 28.53 | 28.06 | 28.43 |
| Reconciled Depreciation | - | 22.14 | 21.78 | 22.32 | 18.74 |
| Reconciled Cost Of Revenue | - | 417.23 | 400.21 | 418.01 | 360.93 |
| Total Unusual Items | - | -0.73 | -1.32 | -73.12 | -42.50 |
| Total Unusual Items Excluding Goodwill | - | -0.73 | -1.32 | -73.12 | -42.50 |
| Earnings From Equity Interest Net Of Tax | -0.39 | 0 | 0 | - | - |
| Special Income Charges | - | 0 | -0.96 | -70.76 | -42.06 |
| Other Special Charges | - | - | - | 1.18 | 9.73 |
| Impairment Of Capital Assets | - | 0 | 0 | 50.41 | 25.40 |
| Restructuring And Mergern Acquisition | - | 0 | 0.96 | 20.16 | 7.19 |
| Gain On Sale Of Security | - | -0.73 | -0.36 | -2.36 | -0.44 |
| Depreciation Amortization Depletion Income Statement | - | 13.95 | 13.28 | 13.34 | 12.12 |
| Depreciation And Amortization In Income Statement | - | 13.95 | 13.28 | 13.34 | 12.12 |
| General And Administrative Expense | - | 53.46 | 48.55 | 56.38 | 53.08 |
| Other Gand A | - | 53.46 | 48.55 | 56.38 | 53.08 |
| Gain On Sale Of Ppe | - | 0 | 0 | 1 | 0.25 |
| Total Other Finance Cost | 0.36 | 0.29 | 0.26 | - | 1.91 |
| Other Operating Expenses | - | - | 0.96 | 20.16 | - |
| Selling And Marketing Expense | - | 101.48 | 56.02 | 48.73 | 45.43 |
| Amortization | - | 13.95 | 13.28 | 13.34 | 12.12 |
| Amortization Of Intangibles Income Statement | - | 13.95 | 13.28 | 13.34 | 12.12 |
Basic Materials sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| American Vanguard Corporationthis co. | AVD | $72M | -1.44 | 0.37 | -25.9% | -21.27 |
| Montauk Renewables, Inc. | MNTK | $242M | 138.43 | 0.92 | 0.7% | 11.03 |
| Hudson Technologies, Inc. | HDSN | $231M | 13.88 | 0.95 | 6.8% | 8.03 |
| Core Molding Technologies, Inc. | CMT | $203M | 18.11 | 1.28 | 7.1% | 7.27 |
| FutureFuel Corp. | FF |
| - |
| - |
| - |
| - |
| - |
| - |
| $192M |
| -3.88 |
| 1.24 |
| -31.9% |
| - |
| Friedman Industries, Incorporated | FRD | $173M | 28.48 | 1.31 | 4.6% | 15.79 |
| Smith-Midland Corporation | SMID | $164M | 13.08 | 3.01 | 23.0% | 7.76 |
| Ascent Industries Co. | ACNT | $123M | 141.88 | 1.41 | 1.0% | -28.63 |
| Trinseo PLC | TSEOF | $0M | -0.00 | -0.00 | 49.7% | 39.40 |
| Peer Median | - | 15.99 | 1.26 | 5.7% | 8.03 | |